tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Paradigm Biopharmaceuticals Issues 7 Million Convertible Notes
PremiumCompany AnnouncementsParadigm Biopharmaceuticals Issues 7 Million Convertible Notes
27d ago
Paradigm Biopharmaceuticals Completes Share Issuance Under Convertible Securities Agreement
Premium
Company Announcements
Paradigm Biopharmaceuticals Completes Share Issuance Under Convertible Securities Agreement
1M ago
Paradigm Biopharmaceuticals Announces Quotation of New Securities
Premium
Company Announcements
Paradigm Biopharmaceuticals Announces Quotation of New Securities
1M ago
Paradigm Biopharmaceuticals Advances Phase 3 Knee Osteoarthritis Trial
PremiumCompany AnnouncementsParadigm Biopharmaceuticals Advances Phase 3 Knee Osteoarthritis Trial
2M ago
Paradigm Biopharmaceuticals’ General Meeting Results and Future Meeting Plans
Premium
Company Announcements
Paradigm Biopharmaceuticals’ General Meeting Results and Future Meeting Plans
2M ago
Paradigm Biopharmaceuticals Secures US Ethics Approval for Phase 3 Osteoarthritis Trial
Premium
Company Announcements
Paradigm Biopharmaceuticals Secures US Ethics Approval for Phase 3 Osteoarthritis Trial
3M ago
Paradigm Biopharmaceuticals Secures Ethics Approval for Phase 3 Osteoarthritis Trial
PremiumCompany AnnouncementsParadigm Biopharmaceuticals Secures Ethics Approval for Phase 3 Osteoarthritis Trial
5M ago
Paradigm Biopharmaceuticals Director Acquires New Options
Premium
Company Announcements
Paradigm Biopharmaceuticals Director Acquires New Options
6M ago
Paradigm Biopharmaceuticals Announces Director’s Securities Interest Update
Premium
Company Announcements
Paradigm Biopharmaceuticals Announces Director’s Securities Interest Update
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100